WWM
AGN

Western Wealth Management’s Allergan plc AGN Stock Holding History

Western Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,414
Closed -$249K – 457
2020
Q1 		$249K Buy
1,414
+114
+9% +$21.5K 0.06% 300
2019
Q4 		$248K Sell
1,300
-132
-9% -$23.8K 0.04% 348
2019
Q3 		$240K Buy
+1,432
New +$233K 0.05% 342

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Western Wealth Management's AGN Position: Q2 2020 in Review

Western Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,414 shares — an estimated $249K sold.

Western Wealth Management first reported a position in AGN in Q3 2019 and held it in 3 quarters. The position peaked at $249K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Western Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Western Wealth Management sold 1,414 Allergan plc shares in Q2 2020, an estimated $249K.
  • Western Wealth Management first reported a position in Allergan plc in Q3 2019 and held it in 3 quarters.
  • Western Wealth Management's Allergan plc position peaked at $249K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Western Wealth Management's 13F filing for Q2 2020, filed 20 Jul 2020.